Literature DB >> 16086444

Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma.

Naohide Oue1, Yoshitsugu Mitani, Phyu Phyu Aung, Chouhei Sakakura, Yukio Takeshima, Mayumi Kaneko, Tsuyoshi Noguchi, Hirofumi Nakayama, Wataru Yasui.   

Abstract

Regenerating islet-derived family, member 4 (Reg IV) is a candidate marker for cancer and inflammatory bowel disease. In the present study, immunohistochemical analysis of Reg IV was performed in various human neoplastic (n = 289) and non-neoplastic tissues. In the stomach, foveolar epithelium was negative for Reg IV, whereas goblet cells of intestinal metaplasia and neuroendocrine cells at the base of intestinal metaplasia expressed Reg IV. Neuroendocrine cells of the small intestine and colon showed strong expression of Reg IV, whereas goblet cells of the small intestine and colon showed weak or no expression of Reg IV. Insulin-producing beta cells of the endocrine pancreas were positive for Reg IV. Among 143 gastric adenocarcinomas, Reg IV expression was detected in 42 (29.4%) and was associated with both the intestinal mucin phenotype and neuroendocrine differentiation. No association was found between Reg IV expression and clinical characteristics such as tumour stage and patient prognosis. Of 36 colorectal adenocarcinomas, 13 (36.1%) were positive for Reg IV, which was associated with tumour stage (p = 0.0379, Fisher's exact test). Expression of Reg IV was detected in 14 (93.3%) of 15 colorectal carcinoid tumours. Reg IV expression was also detected in 5 (21.7%) of 23 ductal adenocarcinomas of the pancreas. In contrast, lung cancers (n = 30) and breast cancers (n = 30) did not express Reg IV. This is the first immunohistochemical analysis of the expression and distribution of Reg IV protein in human tumours. These data suggest that Reg IV is expressed by gastrointestinal and pancreatic tumours, including adenocarcinomas and carcinoid tumours, and that Reg IV is associated with intestinal and neuroendocrine differentiation of the stomach and gastric carcinoma. Copyright (c) 2005 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16086444     DOI: 10.1002/path.1827

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  38 in total

1.  Selective gene expression by rat gastric corpus epithelium.

Authors:  M Goebel; A Stengel; N W G Lambrecht; G Sachs
Journal:  Physiol Genomics       Date:  2010-12-21       Impact factor: 3.107

2.  REG4 is an indicator for KRAS mutant lung adenocarcinoma with TTF-1 low expression.

Authors:  Si Sun; Zhihuang Hu; Shenglin Huang; Xun Ye; Jialei Wang; Jianhua Chang; Xianghua Wu; Qifeng Wang; Lanlin Zhang; Xingjiang Hu; Hui Yu
Journal:  J Cancer Res Clin Oncol       Date:  2019-08-19       Impact factor: 4.553

3.  RegIV expression showing specificity to gastrointestinal tract and its potential role in diagnosing digestive tract neuroendocrine tumor.

Authors:  Feng-ying Li; Xiao-bin Ren; En-ping Xu; Qiong Huang; Hong-qiang Sheng; Bing-jian Lv; Mao-de Lai
Journal:  J Zhejiang Univ Sci B       Date:  2010-04       Impact factor: 3.066

4.  Global analysis of the human gastric epithelial transcriptome altered by Helicobacter pylori eradication in vivo.

Authors:  M B Resnick; E Sabo; P A Meitner; S S Kim; Y Cho; H K Kim; R Tavares; S F Moss
Journal:  Gut       Date:  2006-04-26       Impact factor: 23.059

5.  Gene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer.

Authors:  Hyuk-Joon Lee; Ki Taek Nam; Heae Surng Park; Min A Kim; Bonnie J Lafleur; Hiroyuki Aburatani; Han-Kwang Yang; Woo Ho Kim; James R Goldenring
Journal:  Gastroenterology       Date:  2010-04-13       Impact factor: 22.682

Review 6.  Significance of regenerating islet-derived type IV gene expression in gastroenterological cancers.

Authors:  Masakatsu Numata; Takashi Oshima
Journal:  World J Gastroenterol       Date:  2012-07-21       Impact factor: 5.742

7.  Reg IV enhances peritoneal metastasis in gastric carcinomas.

Authors:  H Kuniyasu; N Oue; T Sasahira; L Yi; Y Moriwaka; T Shimomoto; K Fujii; H Ohmori; W Yasui
Journal:  Cell Prolif       Date:  2009-02       Impact factor: 6.831

8.  Fukutin, identified by the Escherichia coli ampicillin secretion trap (CAST) method, participates in tumor progression in gastric cancer.

Authors:  Htoo Zarni Oo; Kazuhiro Sentani; Shoichiro Mukai; Takuya Hattori; Shunsuke Shinmei; Keisuke Goto; Naoya Sakamoto; Yutaka Naito; Katsuhiro Anami; Pharm Thi Binh Trang; Kazuyoshi Yanagihara; Naohide Oue; Wataru Yasui
Journal:  Gastric Cancer       Date:  2015-07-30       Impact factor: 7.370

Review 9.  New insights into the functions and localization of the homeotic gene CDX2 in gastric cancer.

Authors:  Lin-Hai Yan; Wei-Yuan Wei; Yu-Bo Xie; Qiang Xiao
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

10.  Abnormal growth factor/cytokine network in gastric cancer.

Authors:  Eiichi Tahara
Journal:  Cancer Microenviron       Date:  2008-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.